Publications Correction to: Preclinical SPECT and PET: Joint EANM and ESMI procedure guideline for implementing an efficient quality control programme.Vanhove C, Koole M, Fragoso Costa P, Schottelius M, Mannheim J, Kuntner C, Warnock G, McDougald W, Tavares A, Bernsen M.Eur J Nucl Med Mol Imaging. 2025 Mar;52(4):1600. doi: 10.1007/s00259-024-06890-9.PMID: 3920748Distinct bone metabolic networks identified in Phospho1-/- mice vs. wild type mice using [18F]FDG total-body PET.Hellman AF, Clegg PS, Farquharson C, Millán JL, Alcaide-Corral CJ, Suchacki KJ, Tavares AAS.Front Med (Lausanne). 2025 May 21;12:1597844. doi: 10.3389/fmed.2025.1597844. eCollection 2025.PMID: 40470038Innate [18F]Fluorodeoxyglucose PET bone networks of lung cancer patients predict survival.Ronghe R, Crespo Gonzalez T, Wimberley C, Suchacki K, Tavares AAS.Eur J Nucl Med Mol Imaging. 2025 Nov;52(13):4952-4962. doi: 10.1007/s00259-025-07388-8. Epub 2025 Jun 5.PMID: 40471319The impact of aging and biological sex on cardiac collagen metabolism.Pandya K, Menendez A, MacAskill MG, Gray GA, Tavares AAS.Mech Ageing Dev. 2025 Aug;226:112079. doi: 10.1016/j.mad.2025.112079. Epub 2025 Jun 5.PMID: 40482725Total-body positron emission tomography imaging to accelerate radiotracer discovery pipelines.Sutherland A, Dweck MR, Newby DE, Tavares AAS.Pharmacol Rev. 2025 Jul;77(4):100066. doi: 10.1016/j.pharmr.2025.100066. Epub 2025 May 15.PMID: 40505474Characterization of in vivo binding kinetics and non-displaceable binding of [18F]SynvesT-1 in the rat brain.Wimberley C, Alcaide-Corral CJ, Morgan TEF, Macaskill MG, Andrews B, McErlain H, Burianova VK, Sutherland A, Tavares AAS.EJNMMI Res. 2025 Jun 18;15(1):72. doi: 10.1186/s13550-025-01270-2.PMID: 40533661SV2A is expressed in synapse subpopulations in mouse and human brain: implications for PET radiotracer studies.Wong T, Qiu Z, Notman B, Tavares A, Smith C, Grant SGN.Wellcome Open Res. 2025 Aug 11;10:415. doi: 10.12688/wellcomeopenres.24668.1. eCollection 2025.PMID: 41229902Comparison of multi-organ CT image segmentation tools for whole-body [18F]FDG-PET/CT clinical imaging.Wheeler C, Khaing PH, D'Arnese E, Tavares AAS.Eur J Nucl Med Mol Imaging. 2026 Apr;53(5):3172-3181. doi: 10.1007/s00259-025-07666-5. Epub 2025 Nov 27.PMID: 41307699Comparing three methodologies for network analysis of human [11C]glyburide whole-body PET data: d-networks, s-networks, and ΔPCC networks.Hellman AF, Clegg PS, Marie S, Tournier N, Tavares AAS.EJNMMI Res. 2025 Dec 31;16(1):24. doi: 10.1186/s13550-025-01348-x.PMID: 41474504Performance evaluation of the nanoScan® P123S total-body PET.Réti D, Corral CA, Cranston I, Reid VJM, O'Rourke KM, Morgan TEF, Montagne A, Jansen MA, Burianova VK, Sutherland A, Major P, Nagy K, Bagaméry G, Tavares AAS.EJNMMI Phys. 2025 Dec 8;13(1):2. doi: 10.1186/s40658-025-00817-5.PMID: 41359287Loss of conserved long non-coding RNA MIR503HG leads to altered NOTCH pathway signalling and left ventricular non-compaction cardiomyopathy.Monteiro JP, Saha D, Spiroski AM, Mahesh S, Kaltzis P, Nadavallil A, Janbandhu V, Murray NJ, Severi F, De Pace AL, Sánchez-Esteban S, Rodor J, Beqqali A, Bennett M, Stewart K, Thomson A, Hadoke PWF, Markose D, Wilson-Kanamori JR, Henderson NC, O'Carroll D, Quertermous T, Harvey RP, Del Monte-Nieto G, Baker AH.Cardiovasc Res. 2025 Apr 4:cvaf043. doi: 10.1093/cvr/cvaf043. print.PMID: 40183391ResNet versus U-net for measurements of imaging performance of ultrasound scanners.Bricout A, Hardman D, Inglis S, Pye S, Pires L, Moran CM. Medical Image Understanding and Analysis (MIUA’2025), Frontiers Media SA; 2025, p. 17–24.Novel peri-vascular macrophage mechanism to promote glymphatic amyloid-beta clearance after stroke. Li C, Li T, Hu M, Kang X, Su X, Wang S, Lu D, Shen S, Huang H, Deng X, Liu Y, Lu Z, Farr TD, Cai W. Stroke. 2025. 56(9): 2695-2706Alterations in cardiac function correlate with a disruption in fatty acid metabolism in a mouse model of SMA. Nair NN, Kline RA, Boyd I, Anikumar M, Thomson A, Lamont DJ, Gray GA, Wishart TM, Murray LM.Hum Mol Genet. 2025 Jan 15:ddaf006Multi-organ kinetic modeling for Na[18F]F pre-clinical total-body PET studies. Benitez-Aurioles J, Clegg PS, Alcaide-Corral CJ, Wimberley C, Tavares AAS.Med Phys. 2025 Feb;52(2):924-937. Synthesis and evaluation of 6-arylaminobenzamides as positron emission tomography imaging ligands for the sphingosine-1-phosphate-5 receptor. Morgan TEF, Grant EK, Shaw RC, Waddell LJN, Henry MC, McErlain H, Alcaide-Corral CJ, Pimlott SL, Tavares AAS, Sutherland A.RSC Med Chem. 2025 Jan 3. Assessment of a 6-arylaminobenzamide lead derivative as a potential core scaffold for S1P5 positron emission tomography radiotracer development. Shaw RC, Morgan TEF, McErlain H, Alcaide-Corral CJ, Waldman AD, Soloviev D, Lewis DY, Sutherland A, Tavares AAS.Bioorg Med Chem. 2025 Jan 3;119:118057. This article was published on Tuesday 4 February 2025
